DexCom Inc (DXCM)
74.46
-0.78
(-1.04%)
USD |
NASDAQ |
Nov 21, 16:00
74.60
+0.14
(+0.19%)
After-Hours: 20:00
DexCom Revenue (Quarterly): 994.20M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 994.20M |
| June 30, 2024 | 1.004B |
| March 31, 2024 | 921.00M |
| December 31, 2023 | 1.034B |
| September 30, 2023 | 975.00M |
| June 30, 2023 | 871.30M |
| March 31, 2023 | 741.50M |
| December 31, 2022 | 815.20M |
| September 30, 2022 | 769.60M |
| June 30, 2022 | 696.20M |
| March 31, 2022 | 628.80M |
| December 31, 2021 | 698.20M |
| September 30, 2021 | 650.20M |
| June 30, 2021 | 595.10M |
| March 31, 2021 | 505.00M |
| December 31, 2020 | 568.90M |
| September 30, 2020 | 500.90M |
| June 30, 2020 | 451.80M |
| March 31, 2020 | 405.10M |
| December 31, 2019 | 462.80M |
| September 30, 2019 | 396.30M |
| June 30, 2019 | 336.40M |
| March 31, 2019 | 280.50M |
| December 31, 2018 | 338.00M |
| September 30, 2018 | 266.70M |
| Date | Value |
|---|---|
| June 30, 2018 | 242.50M |
| March 31, 2018 | 184.40M |
| December 31, 2017 | 221.00M |
| September 30, 2017 | 184.60M |
| June 30, 2017 | 170.60M |
| March 31, 2017 | 142.30M |
| December 31, 2016 | 171.20M |
| September 30, 2016 | 148.60M |
| June 30, 2016 | 137.30M |
| March 31, 2016 | 116.20M |
| December 31, 2015 | 130.80M |
| September 30, 2015 | 105.20M |
| June 30, 2015 | 93.20M |
| March 31, 2015 | 72.80M |
| December 31, 2014 | 84.30M |
| September 30, 2014 | 69.00M |
| June 30, 2014 | 58.80M |
| March 31, 2014 | 47.10M |
| December 31, 2013 | 51.70M |
| September 30, 2013 | 42.90M |
| June 30, 2013 | 35.80M |
| March 31, 2013 | 29.60M |
| December 31, 2012 | 33.30M |
| September 30, 2012 | 23.10M |
| June 30, 2012 | 23.40M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
405.10M
Minimum
Mar 2020
1.034B
Maximum
Dec 2023
714.48M
Average
697.20M
Median
Revenue (Quarterly) Benchmarks
| Orthofix Medical Inc | 196.61M |
| Abbott Laboratories | 10.64B |
| Edwards Lifesciences Corp | 1.354B |
| Senseonics Holdings Inc | 4.263M |
| Insulet Corp | 543.90M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 134.60M |
| Total Expenses (Quarterly) | 842.20M |
| EPS Diluted (Quarterly) | 0.34 |
| Enterprise Value | 29.03B |
| Gross Profit Margin (Quarterly) | 59.73% |
| Profit Margin (Quarterly) | 13.54% |
| Earnings Yield | 2.24% |
| Operating Earnings Yield | 2.03% |
| Normalized Earnings Yield | 2.243 |